"Researchers have been working to develop a vaccine that provides long-term, reliable protection from malaria. An effective vaccine could protect people living in malaria-endemic regions as well as travelers and military personnel.
A severe allergic reaction (eg, anaphylaxis) after a previous dose of DECAVAC vaccine or any other tetanus toxoid or diphtheria toxoid containing vaccine or any other component of this vaccine is a contraindication to administration of DECAVAC vaccine. [See DESCRIPTION] Because of uncertainty as to which component of the vaccine may be responsible, no further vaccination with diphtheria or tetanus components should be carried out. Alternatively, such individuals may be referred to an allergist for evaluation if further immunizations are to be considered.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 9/29/2014
Additional Decavac Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.